FR 183998
Alternative Names: FR183998Latest Information Update: 17 Jul 2002
At a glance
- Originator Fujisawa
- Class Anti-ischaemics; Antiarrhythmics; Cardiotonics; Guanidines; Small molecules; Thiophenes
- Mechanism of Action Sodium-hydrogen antiporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Heart failure; Ischaemic heart disorders
Most Recent Events
- 23 Jun 1998 Commercial data has been reviewed by Fujisawa
- 03 Oct 1997 Preclinical development for Arrhythmias in Japan (IV)
- 03 Oct 1997 Preclinical development for Heart failure in Japan (IV)